Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/ T‐ cell lymphoma: A multicenter study-Reference-Cited by-同舟云学术

Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/ T‐ cell lymphoma: A multicenter study

Published:2021-09-13 Issue:11 Volume:96 Page:1481-1490
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Zhang Yuchen¹²,Ma Shuyun¹²,Cai Jun¹²,Yang Yu³,Jing Hongmei⁴^ORCID,Shuang Yuerong⁵,Peng Zhigang⁶,Li Bingzong⁷^ORCID,Liu Panpan¹²^ORCID,Xia Zhongjun¹⁸,Xia Yi¹²,Gao Yan¹²,Chen Daoguang³,Lin Jianyang³,Li Qihui⁴,Xu Shenghua⁵,Xu Qingyuan⁶,Zhang Han⁷,Huang Huiqiang¹²,Cai Qingqing¹²^ORCID

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou China

2. Department of Medical Oncology Sun Yat‐sen University Cancer Center Guangzhou China

3. Department of Lymphadenoma and Head & Neck Medical Oncology Fujian Provincial Cancer Hospital & Institute Fuzhou China

4. Department of Hematology, Lymphoma Research Center Peking University Third Hospital Beijing China

5. Department of Lymphohematology and Oncology Jiangxi Cancer Hospital Nanchang China

6. Department of Medical Oncology First Affiliated Hospital of Guangxi Medical University Nanning China

7. Department of Hematology Second Affiliated Hospital with Suzhou University Suzhou China

8. Department of Hematology Sun Yat‐sen University Cancer Center Guangzhou China

Funder

Chinese Society of Clinical Oncology

Guangdong Science and Technology Department

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26335

Reference51 articles.

1. Mortality of lymphoma and myeloma in China, 2004–2017: an observational study

2. Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma

3. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group

4. BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

5. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma;Hematology;2024-09-13

2. LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma;Cell Death & Disease;2024-08-20

3. Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data;Frontiers in Oncology;2024-07-31

4. Acute myeloid leukemia following remission of AIDS-associated extra-nodal NK/T-cell lymphoma;Heliyon;2024-07

5. Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging;Cell Reports Medicine;2024-05